From October 1, 2023 to December 31, 2023, the company has repurchased 2,000,000 shares, representing 1.79% for $276 million. With this, the company has completed the repurchase of 93,268,933 shares, representing 66% for $8,468.56 million under the buyback announced on October 20, 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,775 GBX | +0.10% | +2.82% | +22.55% |
05-08 | Gsk plc Announces Board Committee Changes | CI |
05-08 | GSK : Receives a Buy rating from Bernstein | ZD |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,775 GBX | +0.10% | +2.82% | 90.35B | ||
136.1 USD | -0.58% | -1.03% | 15.12B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.55% | 90.35B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+16.00% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.